Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches
Corey T. McMillan(University of Pennsylvania), Michael Benatar(University of Miami), Jessica Stark(University of Miami), Joanne Wuu(University of Miami), Sanjay Kalra(University of Miami), Volkan Granit(Biohaven Pharmaceuticals (United States)), Wendy Johnston(University of Alberta), Angela Genge(Montreal Neurological Institute and Hospital), Katya Rascovsky(University of Pennsylvania), Lawrence Korngut(University of Calgary), Lorne Zinman(Sunnybrook Health Science Centre), Murray Grossman(University of Pennsylvania), Stephanie Cosentino(Columbia University), Colin Quinn(University of Pennsylvania), Lauren Elman(University of Pennsylvania), Luis Rosario(University of Pennsylvania), Christen Shoesmith(Western University), Annie Dionne(Université Laval), Hannah Briemberg(University of British Columbia), Sneha Chenji(University of Calgary)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
March 7, 2022
Cited by 41
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
|Nature Genetics|2010|608